| http://dbpedia.org/ontology/abstract
|
Intercell est une entreprise autrichienne ayant fait partie de l'indice ATX. En mai 2013, elle a fusionné avec l'entreprise française Vivalis SA pour former Valneva SE.
, Die Intercell AG war ein österreichisches … Die Intercell AG war ein österreichisches Biotechnologieunternehmen mit Sitz in Wien, das auf die Entwicklung von prophylaktischen und therapeutischen Impfstoffen gegen Infektionskrankheiten spezialisiert war. Intercell kooperierte mit den Pharmaunternehmen Novartis, MSD oder Sanofi-Aventis. Am 28. Mai 2013 vereinigte sich das Unternehmen mit der französischen Vivalis SA zu einer Firma mit dem Unternehmensnamen Valneva SE.irma mit dem Unternehmensnamen Valneva SE.
, Intercell AG was a biotechnology company b … Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna.It employs 400 people in Austria, Scotland and the United States. It has been listed on the Vienna Stock Exchange since February 28, 2005. In 2008, Intercell signaled its intent to acquire Maryland-based , a developer of needle-free vaccination technology. Intercell cooperates with pharmaceutical companies like Novartis, Merck and Sanofi-Aventis on vaccine production. The most important projects of Intercell are:
* Vaccine against Japanese encephalitis (approved in Europe, America and Australia)
* Therapeutic vaccine against hepatitis C (in clinical phase II)
* Antigen identification program and adjuvant technologies.
* Vaccine Enhancement Patch to improve prevention against pandemic influenza (in collaboration with U.S. Department of Health and Human Services, in clinical phase II) and Human Services, in clinical phase II)
|
| http://dbpedia.org/ontology/assets
|
2.252E8
|
| http://dbpedia.org/ontology/equity
|
1.211E8
|
| http://dbpedia.org/ontology/fate
|
Merged with Vivalis SA
|
| http://dbpedia.org/ontology/foundingYear
|
1998
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Chief_executive_officer +
|
| http://dbpedia.org/ontology/netIncome
|
2.552E8
|
| http://dbpedia.org/ontology/numberOfEmployees
|
410
|
| http://dbpedia.org/ontology/operatingIncome
|
2.512E8
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Vaccine +
|
| http://dbpedia.org/ontology/revenue
|
3.42E7
|
| http://dbpedia.org/ontology/successor
|
http://dbpedia.org/resource/Valneva_SE +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Intercell.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Aktiengesellschaft +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.intercell.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
17861621
|
| http://dbpedia.org/ontology/wikiPageLength
|
6261
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1092501414
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Hepatitis_C +
, http://dbpedia.org/resource/Austria +
, http://dbpedia.org/resource/Antigen +
, http://dbpedia.org/resource/Merck_&_Co. +
, http://dbpedia.org/resource/United_States_Department_of_Health_and_Human_Services +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/OTCQX +
, http://dbpedia.org/resource/Aktiengesellschaft +
, http://dbpedia.org/resource/Valneva_SE +
, http://dbpedia.org/resource/Novartis +
, http://dbpedia.org/resource/Supervisory_board +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Research_spin-off +
, http://dbpedia.org/resource/Iomai +
, http://dbpedia.org/resource/Category:Defunct_companies_of_Austria +
, http://dbpedia.org/resource/Vienna_Stock_Exchange +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Austria +
, http://dbpedia.org/resource/Sanofi-Aventis +
, http://dbpedia.org/resource/Category:Technology_companies_established_in_1998 +
, http://dbpedia.org/resource/Adjuvant +
, http://dbpedia.org/resource/Therapeutic_vaccines +
, http://dbpedia.org/resource/Vienna +
, http://dbpedia.org/resource/Pharmaceutical_company +
, http://dbpedia.org/resource/Vaccine +
, http://dbpedia.org/resource/Wiener_B%C3%B6rse +
, http://dbpedia.org/resource/Research_Institute_of_Molecular_Pathology +
, http://dbpedia.org/resource/Japanese_encephalitis +
, http://dbpedia.org/resource/Influenza +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Maryland +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Companies_based_in_Vienna +
|
| http://dbpedia.org/property/assets
|
2.252E8
|
| http://dbpedia.org/property/equity
|
1.211E8
|
| http://dbpedia.org/property/fate
|
Merged with Vivalis SA
|
| http://dbpedia.org/property/foundation
|
1998
|
| http://dbpedia.org/property/homepage
|
http://www.intercell.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Thomas Lingelbach , Michel Gréco
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Vienna +
|
| http://dbpedia.org/property/locationCountry
|
http://dbpedia.org/resource/Austria +
|
| http://dbpedia.org/property/logo
|
Intercell.svg
|
| http://dbpedia.org/property/logoSize
|
120
|
| http://dbpedia.org/property/name
|
Intercell AG
|
| http://dbpedia.org/property/numEmployees
|
410
|
| http://dbpedia.org/property/products
|
Development of vaccines
|
| http://dbpedia.org/property/revenue
|
3.42E7
|
| http://dbpedia.org/property/successor
|
http://dbpedia.org/resource/Valneva_SE +
|
| http://dbpedia.org/property/tradedAs
|
OTCQX: INRLY
, WBAG: ICLL
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Aktiengesellschaft +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Loss +
, http://dbpedia.org/resource/Template:Austria-company-stub +
, http://dbpedia.org/resource/Template:Portal +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:End_date +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Defunct_companies_of_Austria +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Austria +
, http://dbpedia.org/resource/Category:Companies_based_in_Vienna +
, http://dbpedia.org/resource/Category:Technology_companies_established_in_1998 +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.420362.1 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Intercell?oldid=1092501414&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Intercell.svg +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.intercell.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Intercell +
|
| http://xmlns.com/foaf/0.1/name
|
Intercell AG
|
| owl:sameAs |
http://www.wikidata.org/entity/Q874091 +
, http://rdf.freebase.com/ns/m.0478yh5 +
, http://yago-knowledge.org/resource/Intercell +
, http://dbpedia.org/resource/Intercell +
, http://fr.dbpedia.org/resource/Intercell +
, http://fa.dbpedia.org/resource/%D8%A7%DB%8C%D9%86%D8%AA%D8%B1%D8%B3%D9%84 +
, http://de.dbpedia.org/resource/Intercell +
, https://global.dbpedia.org/id/525WW +
, http://azb.dbpedia.org/resource/%D8%A7%DB%8C%D9%86%D8%AA%D8%B1%D8%B3%D9%84 +
|
| rdf:type |
http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInVienna +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1998 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompanies +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnThePinkSheets +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/ontology/Organisation +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
|
| rdfs:comment |
Intercell est une entreprise autrichienne ayant fait partie de l'indice ATX. En mai 2013, elle a fusionné avec l'entreprise française Vivalis SA pour former Valneva SE.
, Die Intercell AG war ein österreichisches … Die Intercell AG war ein österreichisches Biotechnologieunternehmen mit Sitz in Wien, das auf die Entwicklung von prophylaktischen und therapeutischen Impfstoffen gegen Infektionskrankheiten spezialisiert war. Intercell kooperierte mit den Pharmaunternehmen Novartis, MSD oder Sanofi-Aventis. Am 28. Mai 2013 vereinigte sich das Unternehmen mit der französischen Vivalis SA zu einer Firma mit dem Unternehmensnamen Valneva SE.irma mit dem Unternehmensnamen Valneva SE.
, Intercell AG was a biotechnology company b … Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna.It employs 400 people in Austria, Scotland and the United States. It has been listed on the Vienna Stock Exchange since February 28, 2005. In 2008, Intercell signaled its intent to acquire Maryland-based , a developer of needle-free vaccination technology.per of needle-free vaccination technology.
|
| rdfs:label |
Intercell
|
